Rethinking atherogenic risk: is apolipoprotein B a better biomarker?
Fields of Study & Subjects
Diabetes
Cardiovascular Risks
and Lipoproteins
Lipoproteins and Cardiovascular Health
Adipokines
Inflammation
and Metabolic Diseases
Publication details
- Journal / source
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Volume
- 64
- Issue
- 10
- Pages
- e237–e239
- Publication date
- 9 May 2026
- Language
- EN